Walleye Capital LLC Fate Therapeutics Inc Call Options Transaction History

Walleye Capital LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$4.24 - $11.12 $16,536 - $43,368	-3,900 Reduced 41.05%	5,600 $31,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $59,160 - $142,980	6,000 Added 171.43%	9,500 $95,000
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $73,640 - $126,210	3,500 New	3,500 $78,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $161M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.